Thrive Wealth Management LLC Has $302,000 Stock Holdings in The Cooper Companies, Inc. (NASDAQ:COO)

Thrive Wealth Management LLC lessened its holdings in The Cooper Companies, Inc. (NASDAQ:COO) by 7.6% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 3,286 shares of the medical device company’s stock after selling 270 shares during the period. Thrive Wealth Management LLC’s holdings in Cooper Companies were worth $302,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also modified their holdings of COO. American Century Companies Inc. boosted its position in Cooper Companies by 3.9% during the second quarter. American Century Companies Inc. now owns 42,911 shares of the medical device company’s stock valued at $3,746,000 after purchasing an additional 1,600 shares during the last quarter. Dimensional Fund Advisors LP boosted its position in Cooper Companies by 12.4% during the second quarter. Dimensional Fund Advisors LP now owns 1,341,944 shares of the medical device company’s stock valued at $117,156,000 after purchasing an additional 148,500 shares during the last quarter. Mutual of America Capital Management LLC acquired a new stake in Cooper Companies during the second quarter valued at $2,186,000. Vanguard Personalized Indexing Management LLC boosted its position in Cooper Companies by 13.3% during the second quarter. Vanguard Personalized Indexing Management LLC now owns 19,500 shares of the medical device company’s stock valued at $1,688,000 after purchasing an additional 2,290 shares during the last quarter. Finally, Blair William & Co. IL boosted its position in Cooper Companies by 10.4% during the second quarter. Blair William & Co. IL now owns 39,695 shares of the medical device company’s stock valued at $3,465,000 after purchasing an additional 3,733 shares during the last quarter. Institutional investors and hedge funds own 24.39% of the company’s stock.

Cooper Companies Stock Up 1.3 %

Cooper Companies stock opened at $93.27 on Monday. The stock has a market cap of $18.61 billion, a P/E ratio of 47.83, a P/E/G ratio of 2.29 and a beta of 0.99. The company has a quick ratio of 1.12, a current ratio of 1.91 and a debt-to-equity ratio of 0.32. The Cooper Companies, Inc. has a twelve month low of $84.76 and a twelve month high of $112.38. The company’s 50-day moving average price is $96.54 and its two-hundred day moving average price is $99.08.

Cooper Companies (NASDAQ:COO) last announced its earnings results on Thursday, December 5th. The medical device company reported $1.04 EPS for the quarter, topping the consensus estimate of $1.00 by $0.04. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. The company had revenue of $1.02 billion for the quarter, compared to analysts’ expectations of $1.03 billion. During the same period last year, the firm earned $0.87 earnings per share. The business’s revenue for the quarter was up 9.8% on a year-over-year basis. As a group, analysts expect that The Cooper Companies, Inc. will post 3.98 EPS for the current year.

Analyst Upgrades and Downgrades

A number of research firms recently issued reports on COO. Citigroup reduced their price objective on Cooper Companies from $116.00 to $115.00 and set a “buy” rating for the company in a research report on Friday, December 6th. Needham & Company LLC reissued a “hold” rating on shares of Cooper Companies in a research report on Friday, December 6th. StockNews.com cut Cooper Companies from a “buy” rating to a “hold” rating in a research report on Wednesday, December 11th. Wells Fargo & Company raised their target price on Cooper Companies from $115.00 to $118.00 and gave the company an “overweight” rating in a report on Friday, December 6th. Finally, Morgan Stanley cut their target price on Cooper Companies from $104.00 to $102.00 and set an “equal weight” rating on the stock in a report on Friday, December 6th. Four analysts have rated the stock with a hold rating and nine have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $117.00.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.